No deadline for feedback has been given, but the Commission will consider feedback for fee schedule changes for 2025.
No deadline for feedback has been given, but the Commission will consider feedback for fee schedule changes for 2025.
Public comments for the proposed changes to the fee schedule will be accepted until October 23rd.
Drug payments increased eight-fold since 2018.
The meeting takes place October 16th to discuss the fee schedule and other matters.
Audits will focus on timely and accurate reimbursement, bill reporting, and delivery of benefits.
A November 5th meeting will review fee schedule revisions and certain reimbursement rules.
Requiring prior authorization would likely reduce utilization, and by extension reduce spend.
The AWP discount could go from a fixed 15% to a variable rate set by the BWC, with an annual review.
